Skip to main navigation Skip to search Skip to main content

Shaping the future of postoperative recurrence in Crohn’s disease: personalised approaches with AI-enabled imaging and multi-omics

  • Marietta Iacucci
  • , Irene Zammarchi
  • , Cecilia Lina Pugliano
  • , Giovanni Santacroce
  • , Ivan Capobianco
  • , Snehali Majumder
  • , Andrea Ruffa
  • , Valery Naranjo
  • , Enrico Grisan
  • , Olga Maria Nardone
  • , Subrata Ghosh
  • University College Cork
  • Division of Computer Science and Informatics, School of Engineering, London South Bank University

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)
6 Downloads (Pure)

Abstract

Postoperative recurrence (POR) is a major challenge in the long-term management of Crohn’s disease (CD), affecting up to 70% of patients within the first year after surgical resection. The multifactorial pathogenesis of POR complicates prevention, while evolving surgical techniques and different anastomotic configurations further hinder accurate prediction and monitoring. Current surveillance strategies, including standard ileocolonoscopy and faecal calprotectin, remain limited by suboptimal accuracy, the absence of validated scoring systems and the lack of standardised monitoring intervals. Recent advances in high-resolution endoscopic imaging, such as confocal laser endomicroscopy and endocytoscopy, enable real-time, in vivo microstructural assessment of the anastomosis, offering opportunities for earlier and more precise detection of recurrence. In parallel, developments in intestinal ultrasound and cross-sectional imaging are reshaping non-invasive monitoring by providing transmural evaluation. Beyond imaging, multiomics approaches, spanning genomics, transcriptomics, proteomics, metabolomics and metagenomics, are uncovering novel biological pathways linked to POR, providing new mechanistic insights. Artificial intelligence (AI) has the potential to integrate clinical, endoscopic, imaging and omics data into predictive multimodal models for POR, supporting individualised risk stratification, early detection and personalised treatment strategies. While promising, these innovations require prospective validation, methodological standardisation and integration into clinical workflows before translation into routine practice. This review summarises the current understanding of POR, highlights emerging diagnostic and monitoring technologies and explores how AI-enabled endoscopy and multi-omics approaches may transform future management, paving the way towards precision medicine for POR in CD.
Original languageEnglish
Article numbergutjnl-2025-337171
Pages (from-to)1237-1247
Number of pages11
JournalGut
Volume75
Issue number6
Early online date27 Jan 2026
DOIs
Publication statusE-pub ahead of print - 27 Jan 2026

Cite this